A detailed history of Franklin Resources Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 9,760 shares of TARS stock, worth $415,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,760
Previous 12,164 19.76%
Holding current value
$415,385
Previous $400,000 35.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$32.27 - $55.37 $77,577 - $133,109
-2,404 Reduced 19.76%
9,760 $540,000
Q3 2024

Nov 12, 2024

BUY
$21.54 - $34.6 $22,250 - $35,741
1,033 Added 9.28%
12,164 $400,000
Q2 2024

Aug 14, 2024

BUY
$25.17 - $38.73 $280,167 - $431,103
11,131 New
11,131 $302,000

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.13B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.